citrus/inflammation

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a 371 of PCT/KR2014/005403, filed Jun. 19, 2014, which claims the benefit of KR Patent Application No 10-2013-0077877, filed Jul. 3, 2013, the contents of each of which are incorporated herein by reference. TECHNICAL FIELD The present

FIELD OF THE INVENTION The present invention relates to pharmaceutical compositions for suppressing and relieving itching and inflammation, as well as functional food that can be used in combination with ethical medicaments to enhance the therapeutic effect thereof without causing side

FIELD OF THE INVENTION The present invention relates to pharmaceutical compositions for suppressing and relieving itching and inflammation, as well as functional food that can be used in combination with ethical medicaments to enhance the therapeutic effect thereof without causing side

This application is the U.S. national phase of International Application No. PCT/IB2009/055060, filed 13 Nov. 2009, which designated the U.S. and claims priority to Italian Application No. RM2008A000615, filed 17 Nov. 2008; the entire contents of each of which are hereby incorporated by

BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been

BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been

This application claims priority to Korean Patent Application No. 10-2011-0014441 filed 18 Feb. 2011, the entire contents of which is hereby incorporated by reference. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic composition for skin whitening

PRIORITY DATA AND INCORPORATION BY REFERENCE This application claims benefit of priority to U.S. Provisional Patent Application No. 61/568,210 filed Dec. 8, 2011 which is incorporated by reference in its entirety. BACKGROUND OF THE INVENTION 1. Field of the Invention This invention pertains to

BACKGROUND OF THE INVENTION Field of the Invention This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate

BACKGROUND OF THE INVENTION Field of the Invention This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate